UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 88 filers reported holding UNITY BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $18,000 | -60.0% | 5,999 | -39.1% | 0.00% | – |
| Q2 2021 | $45,000 | -74.7% | 9,858 | -67.0% | 0.00% | – |
| Q1 2021 | $178,000 | +191.8% | 29,841 | +155.8% | 0.00% | – |
| Q4 2020 | $61,000 | +10.9% | 11,668 | -27.7% | 0.00% | – |
| Q3 2020 | $55,000 | -65.6% | 16,143 | -12.9% | 0.00% | – |
| Q2 2020 | $160,000 | +185.7% | 18,531 | +95.0% | 0.00% | – |
| Q1 2020 | $56,000 | -73.6% | 9,505 | -67.6% | 0.00% | – |
| Q4 2019 | $212,000 | +149.4% | 29,345 | +110.0% | 0.00% | – |
| Q3 2019 | $85,000 | -65.6% | 13,971 | -46.3% | 0.00% | – |
| Q2 2019 | $247,000 | +42.0% | 26,021 | +21.4% | 0.00% | – |
| Q1 2019 | $174,000 | +656.5% | 21,434 | +1431.0% | 0.00% | – |
| Q4 2018 | $23,000 | -34.3% | 1,400 | -34.3% | 0.00% | – |
| Q3 2018 | $35,000 | +45.8% | 2,132 | +36.0% | 0.00% | – |
| Q2 2018 | $24,000 | – | 1,568 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mayo Clinic | 1,571,981 | $8,237,000 | 9.91% |
| Invus Financial Advisors, LLC | 1,094,998 | $5,738,000 | 2.40% |
| Founders Fund V Management, LLC | 491,751 | $2,577,000 | 0.66% |
| ALGERT GLOBAL LLC | 51,890 | $272,000 | 0.08% |
| Arbor Wealth Management, LLC | 25,888 | $136,000 | 0.05% |
| Moloney Securities Asset Management, LLC | 41,950 | $220,000 | 0.05% |
| PDT Partners, LLC | 78,800 | $413,000 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 394,957 | $2,070,000 | 0.02% |
| Fort Point Capital Partners LLC | 10,000 | $52,000 | 0.01% |
| Baillie Gifford | 3,803,014 | $19,928,000 | 0.01% |